Eliem Therapeutics IncEliem Therapeutics Inc - ESG Rating & Company Profile powered by AI

Industry Group:Biotechnology & Medical Research

The ESG assessment for Eliem Therapeutics Inc represents the company's transparency towards the UN Sustainable Development Goals. Alternative corporations in the rating peer group for Eliem Therapeutics Inc are displayedin the table. This page is a zero-cost Sustainability analysis for Eliem Therapeutics Inc.

Eliem Therapeutics Inc in the Biotechnology & Medical Research industry gained a UN SDG ESG Transparency Score of 6.7; made up of an environmental score of 4.0, social score of 8.0 and governance score of 8.0.

SDG Transparency Score for Eliem Therapeutics Inc 
Low
0 - 3

6.7

Medium Impact
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for Eliem Therapeutics Inc 
4.0

Environmental

8.0

Social

8.0

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Analytik Jena AG
8.0
High
1Adagio Therapeutics Inc
8.0
High
25Zeltia SA
7.0
High
28Aralez Pharmaceuticals Canada Inc
6.9
High
29Eliem Therapeutics Inc
6.7
High
29Lexagene Holdings Inc
6.7
High
29Awakn Life Sciences Corp
6.7
High
.........
233XLR Medical Corp
0.0
Low
233rEVO Biologics Inc
0.0
Low
.........
View the full peer group of 404 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Eliem Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Eliem Therapeutics Inc disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Eliem Therapeutics Inc report the average age of the workforce?

LockedSign up for free to unlock

Does Eliem Therapeutics Inc reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Eliem Therapeutics Inc disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Eliem Therapeutics Inc disclose cybersecurity risks?

LockedSign up for free to unlock

Does Eliem Therapeutics Inc offer flexible work?

LockedSign up for free to unlock

Does Eliem Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Eliem Therapeutics Inc disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Eliem Therapeutics Inc conduct supply chain audits?

LockedSign up for free to unlock

Does Eliem Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Eliem Therapeutics Inc conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Eliem Therapeutics Inc disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Eliem Therapeutics Inc disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Eliem Therapeutics Inc disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Eliem Therapeutics Inc disclose water use targets?

LockedSign up for free to unlock

Does Eliem Therapeutics Inc have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Eliem Therapeutics Inc have a product recall in the last two years?

LockedSign up for free to unlock

Does Eliem Therapeutics Inc disclose incidents of discrimination?

LockedSign up for free to unlock

Does Eliem Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Eliem Therapeutics Inc issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Eliem Therapeutics Inc disclose parental leave metrics?

LockedSign up for free to unlock

Does Eliem Therapeutics Inc disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Eliem Therapeutics Inc disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Eliem Therapeutics Inc disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Eliem Therapeutics Inc support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Eliem Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Eliem Therapeutics Inc reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Eliem Therapeutics Inc involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Eliem Therapeutics Inc disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Eliem Therapeutics Inc disclose its waste policy?

LockedSign up for free to unlock

Does Eliem Therapeutics Inc report according to TCFD requirements?

LockedSign up for free to unlock

Does Eliem Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Eliem Therapeutics Inc disclose energy use targets?

LockedSign up for free to unlock

Does Eliem Therapeutics Inc disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Eliem Therapeutics Inc have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Eliem Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.

Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Its two lead drug candidates are ETX-810 for chronic pain, which is in Phase IIa clinical trial; and ETX-155 for the treatment of major depressive disorder, perimenopausal depression, and focal onset seizures that is in Phase I clinical trial. The company also develops preclinical pipeline programs, such as Kv7 Program for pain, epilepsy, and depression; and Anxiolytic for the treatment of generalized anxiety disorder. Eliem Therapeutics, Inc. was incorporated in 2018 and is headquartered in Redmond, Washington.

Sorry!

Failed to process!